Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Deamino Arginine Vasopressin and Adrenocorticotropic Hormone

Research Papers that Mention the Interaction

The expected ACTH response to oCRH was enhanced by the concomitant DP administration (peak level, 10.39 +/- 1.12 vs. 21.37 +/- 3.43 pmol/L in SAL infusion plus oCRH injection vs. DP infusion plus oCRH injection, respectively; P < 0.05).
These data confirm that DP potentiates the ACTH response to CRH in humans.
The Journal of clinical endocrinology and metabolism  •  1997  |  View Paper
We therefore hypothesized that the combined stimulation of ACTH secretion with CRH plus desmopressin may further improve the diagnostic outcome of this procedure.
Clinical endocrinology  •  2000  |  View Paper
Studies in patients suffering from melancholic depression indicate a hyper-responsiveness to agonism at the vasopressin receptor type 1B (V(1B)); patients display a heightened ACTH release after challenge with the mixed V(1B)/V(2) (vasopressin receptor type 2) agonist desmopressin in comparison to control subjects.
Progress in brain research  •  2008  |  View Paper
In contrast, a blunted ACTH response to desmopressin was documented throughout the course of vandetanib treatment.
Thyroid : official journal of the American Thyroid Association  •  2017  |  View Paper
Plasma ACTH levels were significantly increased by desmopressin (DDAVP) in 86% of cases with Cushing's disease, especially in microadenomas (90%), while these levels were not affected in normal subjects.
Endocrine journal  •  2009  |  View Paper
Moreover, the combination of serum cortisol suppression >50% after HDDST and an ACTH increase ≥ 35% after the administration of CRH or desmopressin only occurred in CD.
Journal of endocrinological investigation  •  2008  |  View Paper
Intravenous desmopressin administration enhanced both circulating concentrations ofACTH and cortisol by 217.36% (peak vs. baseline) and 67% respectively.
Wiadomosci lekarskie  •  2007  |  View Paper
ACTH levels in the incubation media were elevated with stimulation by DDAVP , AVP, or CRH.
This in vitro study may imply that DDAVP as well as AVP directly stimulates ACTH release from corticotropic adenoma cells.
Brain Tumor Pathology  •  2006  |  View Paper
Desmopressin (DDAVP), an arginine vasopressin analogue, markedly stimulates ACTH secretion in patients with Cushing's disease, in contrast to its minimal effect in normal subjects.
The Journal of endocrinology  •  2003  |  View Paper
While CRH failed to induce an ACTH or cortisol response, intravenous administration of desmopressin led to a 47% increase in serum ACTH and a 42% increase in serum cortisol concentration.
Clinical endocrinology  •  1997  |  View Paper
Show More